Skip to content

From protein production to structure and function

The SPG Laboratory conducts collaborative and investigator-driven research aimed at understanding biological mechanisms at the molecular level. The laboratory combines structural, biochemical, and biophysical approaches to investigate protein structure and function.

Research projects frequently integrate multiple technologies, allowing investigators to move from protein production and characterization through high-resolution structure determination and functional validation. This comprehensive workflow provides a powerful platform for both fundamental biological discovery and translational research applications.

The laboratory maintains expertise across a broad range of structural biology methodologies and works closely with NYSBC core facilities to provide access to advanced instrumentation and specialized technical capabilities.

Methods and Capabilities

Structural Biology

  • X-ray crystallography
  • Single-particle cryo-electron microscopy
  • Structural analysis of protein complexes

Protein Science

  • Recombinant protein expression
  • Protein purification
  • Complex assembly and characterization
  • Protein engineering

Biophysical Characterization

  • Microscale thermophoresis (MST)
  • Protein–protein and protein–ligand interaction analysis
  • Label-free and fluorescence-based binding studies
  • Protein stability and thermal unfolding analysis

Research Areas

  • Structural immunology
  • Structure-guided drug discovery
  • Infectious disease and biodefense research
  • Membrane protein structural biology

Publications

Structures of distinct human acetylcholinesterase tetramer forms in complex with synaptic anchoring proteins

Jonah Cheung, Akira Karasawa

Structure

2026 September

Figure S7 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Figure S8 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Table S2 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Supplementary Data File 1 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Figure S5 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Table S1 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Figure S4 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

Molecular Cancer Therapeutics, Vol. 25, Issue 1, Pages 84-93

2026 January

Data from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Figure S2 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

Figure S3 from Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases

Luca Carta, Rebecca Hutcheson, Carolina L. Bigarella, Sufang Zhang, Simon A. Davis, Michael J. Rudolph, Charles H. Reynolds, Matthias Quick, Theresa M. Williams, Michael Schmertzler, Yaron R. Hadari

2026 January

“We use structure to go after specific problems—how a Lyme-disease antibody locks onto its target, how a small molecule can block ricin or Shiga toxin. Running the whole pipeline in one lab, from the gene to the final structure, lets us follow a single question from a protein sequence to a candidate inhibitor without handing it off.”